Parkinson's disease is a degenerative central nervous system disorder that often impairs motor skills, speech and other functions. We discovered a large Chinese family showing primarily parkinsonism symptoms with autosomal dominant inheritance. Six affected individuals in the family showed typical parkinsonism symptoms, including pill-rolling tremor. Two other affected individuals showed cerebellar ataxia symptoms. A whole-genome scan using the 50K single nucleotide polymorphism array with three different linkage methods detected two positive regions on chromosome 12q24.1 and 5q13.3. The ATXN2 gene, responsible for spinocerebellar ataxia type 2 (SCA2) was located precisely in the center of the positive region on chromosome 12. Further analysis of SCA2 revealed heterozygous pathological CAG expansions in the family. The affected individuals' symptoms were typical of parkinsonism, but complex. Inverse correlation between CAG repeat size and age of onset is not obvious in this pedigree. This parkinsonism-predominant SCA2 family shared the same disease gene locus with other 'standard' SCA2 families, but it is possible that variations in one or more modifier genes might account for the parkinsonism-predominant SCA2 predisposition observed in this pedigree.
INTRODUCTION
Parkinson's disease (PD), a degenerative central nervous system disorder, often impairs motor skills, speech and other functions. 1 It is found worldwide, with incidence rates varying from country to country. The prevalence of PD increases with age. In Europe, PD affects about 1-2% of individuals over 60 years of age. 2 Although there is no cure for PD, further understanding of its genetic risks can improve neuroprotective or preventive approaches. Causative genes for Mendelian-inherited parkinsonism have been identified. Point mutations and multiplications in the SNCA gene have been found in some families with autosomal dominant inheritance. 3, 4 To date, mutations in the LRRK2 gene are the most common cause of Mendelian PD. In studies across several populations, 5-15% of autosomal dominant PD families carried mutations in LRRK2 (see refs 5, 6) . Mutations in three genes, PARK2 (encoding parkin), PINK1 (PARK6) and DJ-1 (PARK7), have been identified in autosomal recessive PD, which is characterized by an early age at onset and therefore referred to as autosomal recessive juvenile parkinsonism. [7] [8] [9] The expanded ATXN2 gene, which causes spinocerebellar ataxia type 2 (SCA2), was found in some families with only or mainly typical parkinsonism. 10, 11 Although some parkinsonism clinical signs such as dystonia and tremor have been described in SCA2, dopamine-responsive parkinsonism has been infrequently described in SCA2 (see ref. 12 ). The sign of dopamine-responsive just has been seen in some Chinese families 13, 14 and some white families. 15, 16 We described here a large family from Hubei, China, that showed primarily autosomal dominant inheritance of parkinsonism symptoms acrossing four generations. Affected family members exhibited typical clinical features of PD, such as pill-rolling tremors and levodopa responsiveness. However, some family members showed cerebellar symptoms. The patients who showed the atypical phenotypes opposed to the typical cerebellar ataxia maybe have more complex genetic causes than normal SCA2 patients. So, we performed a whole-genome linkage study to identify possible genetic causes in this family. At same time, the molecular and clinical features of this family were analyzed.
MATERIALS AND METHODS

Clinical information
The proband (IV-3) was initially diagnosed as PD in 2001, and therefore the family was classified as a PD pedigree. In 2007, we performed neurological examinations for eight patients in the family, and we examined four patients using magnetic resonance imaging (MRI). Blood samples were obtained from patients and unaffected relatives with informed consent. Approval for the study was obtained from the Ethical Committees of participating institutions.
Whole-genome linkage analysis
Genomic DNA was isolated from blood using QIAamp DNA Blood Mini Kits (Qiagen, Shanghai, China). Single nucleotide polymorphism genotyping was performed for 27 individuals from the family (Figure 1 ) using the Human Mapping 50K Xba 240 SNP array (Affymetrix, Santa Clara, CA, USA). Signal intensity data were analyzed using GeneChip DNA analysis software GDAS v.3.0.2.8 (Affymetrix). The genotype data were converted to linkage format using ALOHOMORA software 17 and subjected to quality control routines, including gender check and graphical representation of relationship errors. 18 Mendelian errors were detected with PedCheck, 19 and non-informative markers were deleted before further analysis. Genome-wide non-parametric multipoint linkage, single parametric and single non-parametric linkage analysis were performed using GeneSpring GT software (Agilent, Santa Clara, CA, USA).
Trinucleotide repeat analysis
We screened for mutations in the ATXN2 gene using PCR amplification with previously published SCA-2A and SCA-2B oligonucleotide primers. 20 PCR products were sized precisely using capillary electrophoresis with an ABI 3730xL DNA analyzer (Applied Biosystems, Foster city, CA, USA) and compared with known samples using GeneMapper V3.5 (Applied Biosystems, Foster city, CA, USA). Some samples were isolated from agarose gels and used as DNA templates for sequencing with the Big-dye terminator kit (Applied Biosystems) on the ABI 3730xL analyzer.
RESULTS
Clinical information
The family (Figure 1 ) consisted of 39 members in four generations, with 16 affected members. All family members reside in Hubei Province, China. The inheritance pattern is autosomal dominant. We collected peripheral blood from 27 family members, including 10 affected members. Clinical data were shown in Table 1 
Trinucleotide repeat analysis
We performed SCA2 molecular analysis in all 27 family members. Three types of heterozygous pathological CAG expansion (38, 39 and 40 repeats) and two types of normal repeats (19 and 22) were identified. A borderline 34 CAG repeat was found in the two family members. Genotyopes with repeat numbers for individual family In the branch of II-5, the 39 repeats were shortened to 34 in transmission. III-13 and III-14, who carried 34 trinucleotide repeats, showed no symptoms.
DISCUSSION
We described a levodopa-responsive parkinsonism Chinese family with SCA2 trinucleotide expansions. The symptoms observed in this family were primarily parkinsonism, but complex. Some affected family members showed typical clinical manifestations of parkinsonism. Four of five patients responded to levodopa treatment. One affected individual (IV-4) lacking parkinsonism symptoms was unresponsive to levodopa; MRI analysis of this patient showed marked cerebellar atrophy. Patient IV-8 showed just mild masked face, but his cerebellar symptoms were severe. In other patients (IV-12, IV-16 and IV-17), cerebellar symptoms were minor or absent. Overall, the clinical signs in this family appear most similar to parkinsonism.
Molecular analysis of SCA2 expansion in the family revealed three types of expanded CAG repeats. An inverse correlation has been established between age of SCA2 onset and CAG repeat length, with repeat length accounting for 54-80% of variance. 21, 22 However, such inverse correlation was not observed in our pedigree. In the branches of III-1 and III-2, the age of onset in affected individuals who carried the 38 CAG repeats ranged from 22 to 37. Two other individuals with 38 CAG repeats showed no clinical signs at the time of examination (IV-6, age 37 years in 2007; and IV-7, age 35 years in 2007). The age of onset in the three affected individuals who carried 39 CAG repeats (II-5, IV-16 and IV-17) ranged from 20 to 39 years. Another carrier of 39 CAG repeats (IV-10) showed no clinical signs in 2007, at age 43 years. One of the two individuals who carried 40 CAG repeats had an age at onset of 37 years (IV-12). The other (IV-13) had no clinical signs in 2007, at age 43 years. These observations showed that repeat length alone cannot account for age of onset in this family. Conversely, it is not possible to predict when, or if, the unaffected carriers of expanded CAG repeats will eventually show clinical signs.
Some researches suggested that CAA interruption can lead to phenotypical variation. 23, 24 The results of Sobczak et al. 25 showed that the CAA interruptions are major determinants of the CAG repeat folding in the SCA2 transcripts. The SCA2 transcripts interrupted by the CAA should generate shorter branched hairpins and the uninterrupted repeats transcripts form single slippery hairpins. The patients who carried SCA2 expansions with and without interruptions show two different phenotypes. 23, 24 It may be caused by the different CAG repeat folding that would interact differently with doublestranded RNA binding proteins and interfere with mRNA transcription or translation. 24 That structural organization of CAG expansions with interruption associate with phenotypic variation has been also reported in other neurodegenerative disorders such as SCA1 (see ref. 26 ). In our family, all patients carried the CAG expansions with one CAA interruption, but showed two different phenotypes. The patients IV-4 and IV-8 showed more ataxia symptoms than the other patients. Especially, patient IV-4 had no response to the levodopa treatment and had marked cerebellar atrophy on MRI. The symptoms of IV-4 made him look more like the typical SCA2. Therefore, the phenotypic variation in our family may be caused by other unknown reason such as co-effect of SCA2 gene and some modifier gene, rather than the different CAA interruption.
The SCA2 CAG repeat is highly unstable through intergenerational transmission, with a tendency to expand. One study reported that there are 27 families' SCA2 CAG repeats changed in length among 32 SCA2 families, with a mean increase of 2.2 repeat units. 27 In this family, we observed eight transmissions of an expanded SCA2 CAG repeat with no increase in repeat length. Six transmissions yielded no change, whereas two transmissions yielded contractions. As blood samples from several older patients were not collected, we cannot know exactly which SCA2 CAG repeat increased through intergenerational transmission. The explanation for the relative instability in the 11  21  7  1 7  2  22  1  18  16  13  6  3  1 2  2 0  14  8  4  1 9  10  5 Single Point NPL MultiPoints NPL Single Point Parameritc LOD 9 1 5 Figure 3 Three types of log of odds (LOD) scores were calculated from the genome-wide scan. The LOD score plot was created with GNUPLOT 4.0 (http:// www.gnuplot.info) using the LOD plot-drawing Perl script included in the ALOHOMORA package. On chromosome 12, the highest MultiPoint non-parametric LOD score was 3.5 and the highest SinglePoint parametric LOD score was 2.59. On chromosome 5, the highest MultiPoint non-parametric LOD score was 3.5 and the highest SinglePoint parametric LOD score was 2. 29 Our linkage analysis revealed two positive regions, one at chromosome 12q24.1 and one at chromosome 5q13.3. On chromosome 12, the mutated ATXN2 gene, which causes SCA2, is located in the middle of the linkage-positive region. This demonstrates the accuracy of the detection methods and shows that the positive regions are reliable. As the disease gene of SCA2 was located to chromosome 12q23-24.1 (see ref. 30 ), most of the reports about parkinsonism-predominant SCA2 was based on case cohorts. The linkage study in our family strengthened that the parkinsonism-predominant SCA2 carried the same pathogenic gene as the typical SCA2 from the whole genome perspective. We assume that this parkinsonism-predominant SCA2 family shares a disease locus with other standard SCA2 families, but it is possible that one or more modifier genes interact with ATXN2 to produce clinical signs more similar to parkinsonism. It is difficult to predict whether the other positive region at 5q13.3 is a real positive region or an artifact. If it is not an artifact, perhaps there would be a modifier gene harbored in the region. To prove it, more detailed gene mutation analyses in the region or other linkage analyses for additional parkinsonism-predominant SCA2 families need to be performed.
The prevalence of SCA2 among patients with familial parkinsonism ranged from 1.5 to 10% (ref. 12) . It is seen occasionally in German 28 and Japanese 10 populations. After Gwinn-Hardy et al. 23 reported that four families with SCA2 were identified among 41 families with familial parkinsonism, about 10% of familial parkinsonism carried the expanded SCA2 CAG repeats in Taiwan people. Therefore, it is possible that the mutation rate of potential modifiers might account for the ethnic differences in the predisposition of parkinsonism-predominant SCA2. Better understanding of factors that determine a predominant parkinsonism phenotype in SCA2 may shed light on the pathogenesis of PD.
